Stock Comparison
LLY vs NVO
Side-by-side fundamentals, quality, value, and price momentum analysis.
Selected Stocks
Add up to 10 tickers. Use presets or search to get started.
Metrics Comparison
Best values highlighted in green, worst in red. Scroll horizontally to see all tickers.
LLY vs NVO: Key Questions Answered
Which is the cheapest stock: LLY or NVO?
Based on P/E ratio, Novo Nordisk A/S (NVO) is the cheapest at 2.6x earnings. Eli Lilly and Company (LLY) is the most expensive at 92.0x. A lower P/E can indicate better value, but always consider growth rates too.
Which stock is growing the fastest: LLY or NVO?
Eli Lilly and Company (LLY) is growing the fastest with 32.0% revenue growth. Novo Nordisk A/S has the slowest growth at 25.0%. Higher growth often justifies higher valuations.
Which has the best profit margins: LLY or NVO?
Novo Nordisk A/S (NVO) has the strongest profitability with a 34.8% net margin. Eli Lilly and Company has the lowest at 23.5%. Higher margins indicate pricing power and efficiency.
Which pays the highest dividend: LLY or NVO?
Novo Nordisk A/S (NVO) offers the highest dividend yield of 16.6%. Eli Lilly and Company has the lowest at 0.5%. For income investors, higher yield matters, but check payout sustainability.
Which is the largest company: LLY or NVO?
Eli Lilly and Company (LLY) is the largest company with a market cap of $964.1B. Novo Nordisk A/S is the smallest at $200.9B. Larger companies tend to be more stable but may have less growth potential.
Which stock has the best return on equity: LLY or NVO?
Eli Lilly and Company (LLY) generates the best returns on shareholder equity with an ROE of 84.3%. Novo Nordisk A/S has the lowest at 80.8%. Higher ROE indicates efficient use of capital.